Michelle Hanna is the founder and CEO of Ribomed Biotechnologies, a six-year-old Phoenix-based molecular biology tools startup with approximately $5 million in grants to develop technology for a handheld bioterrorism agents detection device, and the developer of a new laboratory workspace located across the street from the Translational Genomics Institute.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.